Company Filing History:
1 out of 1,743 
1 out of 124 
1 out of 116 
Years Active: 2024
Title: Aude Jaffre: Innovator in Vascular Health
Introduction
Aude Jaffre is a notable inventor based in Toulouse, France. She has made significant contributions to the field of vascular health, particularly in understanding and addressing ischemic conditions. Her work focuses on preserving vascular endothelial cell barrier integrity, which is crucial for patient recovery following ischemic events.
Latest Patents
Aude Jaffre holds a patent titled "Use of PI3KC2B inhibitors for the preservation of vascular endothelial cell barrier integrity." This invention addresses the challenges posed by ischemia, a condition characterized by reduced blood flow and oxygen to an organ. The patent highlights the importance of re-establishing blood flow and oxygenation after an ischemic episode to limit irreversible damage. Jaffre's research demonstrates that genetic inhibition of PI3K-C2β can reduce cerebral infarction in ischemia/reperfusion models and improve neurological outcomes. This genetic inhibition stabilizes the blood-brain barrier after ischemic stroke and reduces inflammation, offering a promising therapeutic approach.
Career Highlights
Throughout her career, Aude Jaffre has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Paul Sabatier Toulouse III. Her research has significantly advanced the understanding of vascular health and the mechanisms underlying ischemic conditions.
Collaborations
Aude Jaffre has collaborated with notable colleagues, including Marie-Pierre Gratacap and Jean Darcourt. These collaborations have enriched her research and contributed to the development of innovative solutions in the field of vascular health.
Conclusion
Aude Jaffre's contributions to the field of vascular health through her innovative patent and collaborative efforts highlight her role as a leading inventor. Her work continues to pave the way for advancements in the treatment of ischemic conditions, ultimately improving patient outcomes.